Chronic stimulation drives human NK cell dysfunction and epigenetic reprograming
- PMID: 31211698
- PMCID: PMC6715389
- DOI: 10.1172/JCI125916
Chronic stimulation drives human NK cell dysfunction and epigenetic reprograming
Abstract
A population of Natural Killer (NK) cells expressing the activating receptor NKG2C and the maturation marker CD57 expands in response to human cytomegalovirus (HCMV) infection. CD3-CD56dimCD57+NKG2C+ NK cells are similar to CD8+ memory T cells with rapid and robust effector function upon re-stimulation, persistence, and epigenetic remodeling of the IFNG locus. Chronic antigen stimulation drives CD8+ memory T cell proliferation while also inducing genome-wide epigenetic reprograming and dysfunction. We hypothesized that chronic stimulation could similarly induce epigenetic reprograming and dysfunction in NK cells. Here we show that chronic stimulation of adaptive NK cells through NKG2C using plate-bound agonistic antibodies in combination with IL-15 drove robust proliferation and activation of CD3-CD56dimCD57+NKG2C+ NK cells while simultaneously inducing high expression of the checkpoint inhibitory receptors LAG-3 and PD-1. Marked induction of checkpoint inhibitory receptors was also observed on the surface of adaptive NK cells co-cultured with HCMV-infected endothelial cells. Chronically stimulated adaptive NK cells were dysfunctional when challenged with tumor targets. These cells exhibited a pattern of epigenetic reprograming, with genome-wide alterations in DNA methylation. Our study has important implications for cancer immunotherapy and suggest that exhausted NK cells could be targeted with inhibitory checkpoint receptor blockade.
Keywords: Immunology; NK cells.
Conflict of interest statement
Figures
Similar articles
-
Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infection.Proc Natl Acad Sci U S A. 2011 Sep 6;108(36):14725-32. doi: 10.1073/pnas.1110900108. Epub 2011 Aug 8. Proc Natl Acad Sci U S A. 2011. PMID: 21825173 Free PMC article.
-
CD56dim CD57- NKG2C+ NK cells retaining proliferative potential are possible precursors of CD57+ NKG2C+ memory-like NK cells.J Leukoc Biol. 2020 Oct;108(4):1379-1395. doi: 10.1002/JLB.1MA0720-654RR. Epub 2020 Sep 15. J Leukoc Biol. 2020. PMID: 32930385 Free PMC article.
-
NKG2C(+)CD57(+) Natural Killer Cell Expansion Parallels Cytomegalovirus-Specific CD8(+) T Cell Evolution towards Senescence.J Immunol Res. 2016;2016:7470124. doi: 10.1155/2016/7470124. Epub 2016 May 29. J Immunol Res. 2016. PMID: 27314055 Free PMC article.
-
The CD94/NKG2C+ NK-cell subset on the edge of innate and adaptive immunity to human cytomegalovirus infection.Semin Immunol. 2014 Apr;26(2):145-51. doi: 10.1016/j.smim.2014.03.002. Epub 2014 Mar 22. Semin Immunol. 2014. PMID: 24666761 Review.
-
Adaptive reconfiguration of the human NK-cell compartment in response to cytomegalovirus: a different perspective of the host-pathogen interaction.Eur J Immunol. 2013 May;43(5):1133-41. doi: 10.1002/eji.201243117. Eur J Immunol. 2013. PMID: 23552990 Review.
Cited by
-
LAG-3 Blockade with Relatlimab (BMS-986016) Restores Anti-Leukemic Responses in Chronic Lymphocytic Leukemia.Cancers (Basel). 2021 Apr 27;13(9):2112. doi: 10.3390/cancers13092112. Cancers (Basel). 2021. PMID: 33925565 Free PMC article.
-
Single-cell profiling identifies impaired adaptive NK cells expanded after HCMV reactivation in haploidentical HSCT.JCI Insight. 2021 Jun 22;6(12):e146973. doi: 10.1172/jci.insight.146973. JCI Insight. 2021. PMID: 34003794 Free PMC article.
-
Natural Killer Cells in Myeloid Malignancies: Immune Surveillance, NK Cell Dysfunction, and Pharmacological Opportunities to Bolster the Endogenous NK Cells.Front Immunol. 2019 Oct 11;10:2357. doi: 10.3389/fimmu.2019.02357. eCollection 2019. Front Immunol. 2019. PMID: 31681270 Free PMC article. Review.
-
NKG2C+ NK Cells for Immunotherapy of Glioblastoma Multiforme.Int J Mol Sci. 2022 May 23;23(10):5857. doi: 10.3390/ijms23105857. Int J Mol Sci. 2022. PMID: 35628668 Free PMC article.
-
Epigenetic regulation of natural killer cell memory.Immunol Rev. 2022 Jan;305(1):90-110. doi: 10.1111/imr.13031. Epub 2021 Dec 14. Immunol Rev. 2022. PMID: 34908173 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous